iRay Group (SHA:688301)
China
· Delayed Price · Currency is CNY 121.00
+6.60 (5.77%)
Apr 1, 2025, 2:45 PM CST
iRay Group Revenue
In the year 2024, iRay Group had annual revenue of 1.86B CNY, down -0.09%. iRay Group had revenue of 506.00M in the quarter ending December 31, 2024, with 8.37% growth.
Revenue
1.86B
Revenue Growth
-0.09%
P/S Ratio
9.25
Revenue / Employee
1.12M
Employees
1,661
Market Cap
17.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.86B | -1.61M | -0.09% |
| Dec 31, 2023 | 1.86B | 314.67M | 20.31% |
| Dec 31, 2022 | 1.55B | 361.76M | 30.47% |
| Dec 31, 2021 | 1.19B | 403.27M | 51.43% |
| Dec 31, 2020 | 784.08M | 237.97M | 43.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Sichuan Biokin Pharmaceutical | 5.82B |